Ross Moat

Insider Reports History

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ross Moat:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kiniksa Pharmaceuticals International, plc CHIEF COMMERCIAL OFFICER Performance Share Unit 5.23K $351K $17.88 May 1, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF COMMERCIAL OFFICER Class A Ordinary Share 9.42K $264K $28.00 May 5, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF COMMERCIAL OFFICER Share Option 27.4K May 5, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF COMMERCIAL OFFICER Performance Share Option 8.3K May 1, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF COMMERCIAL OFFICER Restricted Share Unit 2.48K Apr 7, 2025 Direct

Insider Reports Filed by Ross Moat

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNSA Kiniksa Pharmaceuticals International, plc May 1, 2025 10 -$104K 4 May 5, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Apr 29, 2025 18 -$1.09M 4 May 1, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Apr 21, 2025 1 -$370K 4 Apr 23, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Apr 7, 2025 3 -$14.7K 4 Apr 9, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Apr 1, 2025 9 -$21.4K 4 Apr 3, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Mar 16, 2025 4 $11.3K 4 Mar 19, 2025 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Jul 15, 2024 18 -$1.08M 4 Sep 4, 2024 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 4, 2024 6 -$24.2K 4 Apr 8, 2024 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2024 3 -$17.3K 4 Apr 3, 2024 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Jul 15, 2023 9 -$30.1K 4 Sep 6, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 10, 2023 3 -$14.5K 4 Apr 11, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2023 2 $0 4 Apr 3, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Jan 15, 2023 7 -$1.57K 4 Mar 20, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 1, 2022 6 -$3K 4 Sep 6, 2022 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 7, 2022 2 $0 4 Apr 11, 2022 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 21, 2022 3 -$13.6K 4 Mar 23, 2022 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 2, 2021 2 $0 4 Sep 7, 2021 ARCALYST General Manager
KNSA Kiniksa Pharmaceuticals, Ltd. Jul 15, 2021 5 $20.4K 4 Mar 18, 2022 Chief Commercial Officer